Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2024

Feb 2, 2024

29745_dirs_2024-02-02_e6906b49-2695-4f94-b130-5fbfbde48a56.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-02-01

Reporting Person: Yuffa Ilya (EVP & President, LLY Int'l)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-01 Common Stock M 3702 Acquired 16676 Direct
2024-02-01 Common Stock F 1664 $645.61 Disposed 15012 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-01 Restricted Stock Unit $ M 3702 Disposed 2024-02-01 Common Stock (3702) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.